JHS Svendgaard Laboratories Limited

NSEI:JHS Stock Report

Market Cap: ₹1.9b

JHS Svendgaard Laboratories Valuation

Is JHS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of JHS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: JHS (₹21.71) is trading above our estimate of fair value (₹12.71)

Significantly Below Fair Value: JHS is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for JHS?

Key metric: As JHS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for JHS. This is calculated by dividing JHS's market cap by their current revenue.
What is JHS's PS Ratio?
PS Ratio2.2x
Sales₹828.03m
Market Cap₹1.87b

Price to Sales Ratio vs Peers

How does JHS's PS Ratio compare to its peers?

The above table shows the PS ratio for JHS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.4x
531412 Radix Industries (India)
7xn/a₹2.5b
530689 Lykis
0.2xn/a₹811.4m
524703 Sandu Pharmaceuticals
0.8xn/a₹555.7m
541601 Rajnish Wellness
1.7xn/a₹1.4b
JHS JHS Svendgaard Laboratories
2.2xn/a₹1.9b

Price-To-Sales vs Peers: JHS is good value based on its Price-To-Sales Ratio (2.2x) compared to the peer average (2.4x).

Price to Sales Ratio vs Industry

How does JHS's PS Ratio compare vs other companies in the IN Personal Products Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
530689 Lykis
0.2xn/aUS$9.61m
524703 Sandu Pharmaceuticals
0.8xn/aUS$6.58m
542248 Deccan Health Care
0.8xn/aUS$6.56m
WALPAR Walpar Nutritions
0.6xn/aUS$4.73m
JHS 2.2xIndustry Avg. 6.8xNo. of Companies5PS048121620+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: JHS is good value based on its Price-To-Sales Ratio (2.2x) compared to the Indian Personal Products industry average (6.8x).

Price to Sales Ratio vs Fair Ratio

What is JHS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

JHS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate JHS's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

500096

₹508.25

7D

-0.5%

1Y

-6.1%

Jyothy Labs

₹148.6b

Engages in the manufacture and marketing of fabric care, dishwashing, personal care, and household insecticides products in India and internationally.

JYOTHYLAB

₹404.75

7D

-8.3%

1Y

-9.7%

Emami

₹281.3b

Manufactures and markets personal and healthcare products in India and internationally.

EMAMILTD

₹643.15

7D

-6.9%

1Y

30.2%